These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 6105003

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Compensatory mechanisms in the nigrostriatal dopaminergic system in Parkinson's disease: studies in an animal model.
    Melamed E, Hefti F, Wurtman RJ.
    Isr J Med Sci; 1982 Jan; 18(1):159-63. PubMed ID: 6121770
    [Abstract] [Full Text] [Related]

  • 4. In vivo studies of striatal dopamine release and metabolism following administration of L-dopa.
    Brannan T, Knott P, Kaufmann H, Yahr M.
    Adv Neurol; 1990 Jan; 53():75-81. PubMed ID: 2173378
    [No Abstract] [Full Text] [Related]

  • 5. Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions.
    Melamed E, Hefti F, Wurtman RJ.
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4305-9. PubMed ID: 6254020
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine.
    Moroz IA, Peciña S, Schallert T, Stewart J.
    Exp Neurol; 2004 Sep; 189(1):78-93. PubMed ID: 15296838
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dopamine-mediated circling behaviour does not involve the nigro-tectal pathway.
    Reavill C, Leigh N, Jenner P, Marsden CD.
    Exp Brain Res; 1979 Oct; 37(2):309-16. PubMed ID: 315328
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mesolimbic dopaminergic neurones in the rotational model of nigrostriatal function.
    Kelly PH, Moore KE.
    Nature; 1976 Oct 21; 263(5579):695-6. PubMed ID: 980114
    [No Abstract] [Full Text] [Related]

  • 16. A two-population model of rat rotational behavior: effects of unilateral nigrostriatal 6-hydroxydopamine on striatal neurochemistry and amphetamine-induced rotation.
    Shapiro RM, Glick SD, Camarota NA.
    Brain Res; 1987 Nov 24; 426(2):323-31. PubMed ID: 2446711
    [Abstract] [Full Text] [Related]

  • 17. Injections of 6-hydroxydopamine in the substantia nigra of the rat brain: morphological and biochemical effects.
    Buonamici M, Cervini MA, Rossi AC, Sebastiani L, Raffaelli A, Bagnoli P.
    Behav Brain Res; 1990 Apr 16; 38(1):83-95. PubMed ID: 2112003
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum.
    Elverfors A, Nissbrandt H.
    Neuropharmacology; 1992 Jul 16; 31(7):661-70. PubMed ID: 1328918
    [Abstract] [Full Text] [Related]

  • 20. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats.
    Robertson GS, Fine A, Robertson HA.
    Brain Res; 1991 Jan 25; 539(2):304-11. PubMed ID: 1675908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.